Braun Stacey Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Braun Stacey Associates's CELG Position: Q1 2018 in Review
Braun Stacey Associates sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 75,507 shares — an estimated $7.88M sold.
Braun Stacey Associates first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $12M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.
- Braun Stacey Associates reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
- Braun Stacey Associates sold 75,507 Celgene Corp shares in Q1 2018, an estimated $7.88M.
- Braun Stacey Associates first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
- Braun Stacey Associates's Celgene Corp position peaked at $12M in Q3 2017.
- 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.
Based on Braun Stacey Associates's 13F filing for Q1 2018, filed 1 May 2018.